Literature DB >> 29283681

Short-Term Air Pollution and Incident Pneumonia. A Case-Crossover Study.

Cheryl S Pirozzi1, Barbara E Jones1,2, James A VanDerslice3, Yue Zhang3,4, Robert Paine1,2, Nathan C Dean1,5.   

Abstract

RATIONALE: The relationship between air pollution and pneumonia is poorly understood.
OBJECTIVES: To examine relationships between short-term air pollution exposure and number and severity of pneumonia cases along the Wasatch Front in Utah, a region with periodic high levels of outdoor air pollution.
METHODS: We applied time-stratified case-crossover analyses with distributed lag to patients presenting to seven emergency departments with pneumonia over a 2-year period. We compared levels of particulate matter less than or equal to 2.5 μm in aerodynamic diameter, nitrogen dioxide, and ozone at patient residences with emergency department cases, hospitalizations, objectively defined severe pneumonia, and mortality. We calculated direct cost impacts of particulate matter less than or equal to 2.5 μm in aerodynamic diameter reduction.
RESULTS: We evaluated 4,336 pneumonia cases in seven hospitals. Among adults aged 65 years and older, we found consistently positive associations between particulate matter less than or equal to 2.5 μm in aerodynamic diameter within 6 days of presentation and instances of pneumonia (Lag Day 1 adjusted odds ratio, 1.35 per 10 μg/m3 over 12 μg/m3; 95% confidence interval, 1.16-1.57), severe pneumonia (Lag Day 1 adjusted odds ratio, 1.38; 95% confidence interval, 1.06-1.80), and inpatient mortality (Lag Day 5 adjusted odds ratio, 1.50; 95% confidence interval, 1.03-2.16). Smaller associations were found between nitrogen dioxide exposure and pneumonia occurrence, severity, and inpatient and 30-day mortality. Ozone exposure was modestly associated with increased instance and severity of pneumonia in younger adults. Particulate matter less than or equal to 2.5 μm in aerodynamic diameter and nitrogen dioxide effects were greatest in colder months, and ozone effects were greatest in warmer months. Reduction of particulate matter less than or equal to 2.5 μm in aerodynamic diameter levels to less than 12.0 mg/m3 could prevent 76-112 cases of pneumonia per year in these hospitals serving approximately half of the Wasatch Front's population, reducing direct medical facility costs by $807,000 annually.
CONCLUSIONS: Among older adults, short-term ambient particulate matter less than or equal to 2.5 μm in aerodynamic diameter exposure is associated with more emergency department visits and hospitalizations for pneumonia, severe pneumonia, increased mortality, and increased healthcare costs. Nitrogen dioxide and ozone modestly increase pneumonia risk and illness severity.

Entities:  

Keywords:  healthcare costs; nitrogen dioxide; ozone; particulate matter; respiratory tract infections

Mesh:

Substances:

Year:  2018        PMID: 29283681     DOI: 10.1513/AnnalsATS.201706-495OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  26 in total

Review 1.  The Respiratory Risks of Ambient/Outdoor Air Pollution.

Authors:  Gary Adamkiewicz; Jahred Liddie; Jonathan M Gaffin
Journal:  Clin Chest Med       Date:  2020-12       Impact factor: 2.878

2.  Long-term ozone exposure is positively associated with telomere length in critically ill patients.

Authors:  Chunxue Wang; Paul J Wolters; Carolyn S Calfee; Shuo Liu; John R Balmes; Zhiguo Zhao; Tatsuki Koyama; Lorraine B Ware
Journal:  Environ Int       Date:  2020-05-08       Impact factor: 9.621

3.  Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients.

Authors:  Judy Y Ou; Heidi A Hanson; Joemy M Ramsay; Heydon K Kaddas; Clive Arden Pope; Claire L Leiser; James VanDerslice; Anne C Kirchhoff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-13       Impact factor: 4.254

4.  Could the Air You Breathe Increase Your Risk of Developing Acute Respiratory Distress Syndrome?

Authors:  Robert Paine
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 30.528

5.  Fine Particulate Matter and Respiratory Healthcare Encounters among Survivors of Childhood Cancers.

Authors:  Judy Y Ou; Heidi A Hanson; Joemy M Ramsay; Claire L Leiser; Yue Zhang; James A VanDerslice; C Arden Pope; Anne C Kirchhoff
Journal:  Int J Environ Res Public Health       Date:  2019-03-26       Impact factor: 3.390

6.  The Association between Respiratory Infection and Air Pollution in the Setting of Air Quality Policy and Economic Change.

Authors:  Daniel P Croft; Wangjian Zhang; Shao Lin; Sally W Thurston; Philip K Hopke; Mauro Masiol; Stefania Squizzato; Edwin van Wijngaarden; Mark J Utell; David Q Rich
Journal:  Ann Am Thorac Soc       Date:  2019-03

7.  The Relationship between Pneumocystis Infection in Animal and Human Hosts, and Climatological and Environmental Air Pollution Factors: A Systematic Review.

Authors:  Robert F Miller; Laurence Huang; Peter D Walzer
Journal:  OBM Genet       Date:  2018-10-26

8.  Air Pollution across the Cancer Continuum: Extending Our Understanding of the Relationship between Environmental Exposures and Cancer.

Authors:  Judy Y Ou; Anne C Kirchhoff; Heidi A Hanson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10       Impact factor: 4.254

Review 9.  Climate Change Impacts on Disaster and Emergency Medicine Focusing on Mitigation Disruptive Effects: an International Perspective.

Authors:  Daniel Aiham Ghazali; Maximilien Guericolas; Frédéric Thys; François Sarasin; Pedro Arcos González; Enrique Casalino
Journal:  Int J Environ Res Public Health       Date:  2018-07-01       Impact factor: 3.390

10.  Changes in triggering of ST-elevation myocardial infarction by particulate air pollution in Monroe County, New York over time: a case-crossover study.

Authors:  Meng Wang; Philip K Hopke; Mauro Masiol; Sally W Thurston; Scott Cameron; Frederick Ling; Edwin van Wijngaarden; Daniel Croft; Stefania Squizzato; Kelly Thevenet-Morrison; David Chalupa; David Q Rich
Journal:  Environ Health       Date:  2019-09-06       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.